• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评价:胃食管反流病中质子泵抑制剂的使用和依从模式。

Systematic review: Patterns of proton pump inhibitor use and adherence in gastroesophageal reflux disease.

机构信息

School of Medicine and Health, Wolfson Research Institute, Durham University, Stockton-on-Tees, United Kingdom.

出版信息

Clin Gastroenterol Hepatol. 2012 Feb;10(2):109-16. doi: 10.1016/j.cgh.2011.07.008. Epub 2011 Jul 23.

DOI:10.1016/j.cgh.2011.07.008
PMID:21782770
Abstract

BACKGROUND & AIMS: Variation in how proton pump inhibitors (PPIs) are taken likely influences their clinical effectiveness, and must be considered when estimating PPI failure rates. This review aimed to systematically investigate the literature on patterns of PPI use in patients with gastroesophageal reflux disease (GERD).

METHODS

PubMed and Embase were searched (1989-May 2010) to identify observational studies providing information on patterns of PPI use in patients with GERD.

RESULTS

Of 902 studies identified, 13 met prespecified selection criteria. Across 2 database studies, 53.8%-67.7% of patients with GERD had a medication possession ratio (MPR) of >0.80. Across 2 more database studies, the mean MPR for the study population was 0.68 to 0.84. Across 3 surveys, 70%-84% of patients reported daily PPI use. In 2 surveys, the presence and severity of reflux symptoms increased PPI adherence, as did Barrett's esophagus in another 2 studies. Across 3 surveys, 11%-22.2% of patients reported twice daily PPI use, and across 6 studies 11.0%-44.8% of patients took GERD medication in addition to a PPI.

CONCLUSIONS

The results of this systematic review suggest that the majority of patients with GERD are relatively adherent to their PPI, although substantially different estimates were obtained using MPR data compared with surveys. Severe symptoms and the presence of Barrett's esophagus may increase PPI adherence, and other GERD medication is frequently taken in addition to a PPI. Limitations of studies in this area include inferring adherence from indirect MPR data, and recall bias associated with patient surveys.

摘要

背景与目的

质子泵抑制剂(PPIs)的服用方式可能会影响其临床疗效,在估计 PPI 失败率时必须加以考虑。本综述旨在系统地调查胃食管反流病(GERD)患者中 PPI 使用模式的文献。

方法

在 PubMed 和 Embase 中进行检索(1989 年 5 月-2010 年),以确定提供 GERD 患者 PPI 使用模式信息的观察性研究。

结果

在 902 项研究中,有 13 项符合预先规定的选择标准。在 2 项数据库研究中,有 53.8%-67.7%的 GERD 患者的药物持有率(MPR)>0.80。在另外 2 项数据库研究中,研究人群的平均 MPR 为 0.68-0.84。在 3 项调查中,有 70%-84%的患者报告每天使用 PPI。在 2 项调查中,反流症状的存在和严重程度增加了 PPI 的依从性,另外 2 项研究中 Barrett 食管也是如此。在 3 项调查中,有 11%-22.2%的患者报告每天使用 2 次 PPI,在 6 项研究中有 11.0%-44.8%的患者除 PPI 外还使用 GERD 药物。

结论

本系统综述的结果表明,大多数 GERD 患者对其 PPI 的依从性相对较高,尽管使用 MPR 数据与调查结果相比获得了截然不同的估计。严重的症状和 Barrett 食管的存在可能会增加 PPI 的依从性,并且除 PPI 外还经常使用其他 GERD 药物。该领域研究的局限性包括从间接 MPR 数据推断依从性以及与患者调查相关的回忆偏倚。

相似文献

1
Systematic review: Patterns of proton pump inhibitor use and adherence in gastroesophageal reflux disease.系统评价:胃食管反流病中质子泵抑制剂的使用和依从模式。
Clin Gastroenterol Hepatol. 2012 Feb;10(2):109-16. doi: 10.1016/j.cgh.2011.07.008. Epub 2011 Jul 23.
2
Deprescribing versus continuation of chronic proton pump inhibitor use in adults.成人慢性质子泵抑制剂的撤药与继续用药对比
Cochrane Database Syst Rev. 2017 Mar 16;3(3):CD011969. doi: 10.1002/14651858.CD011969.pub2.
3
Proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug-induced ulcers and dyspepsia.质子泵抑制剂用于预防非甾体抗炎药引起的溃疡和消化不良。
Cochrane Database Syst Rev. 2025 May 8;5(5):CD014585. doi: 10.1002/14651858.CD014585.pub2.
4
Does treatment with proton pump inhibitors for gastroesophageal reflux disease (GERD) improve asthma symptoms in children with asthma and GERD? A systematic review.使用质子泵抑制剂治疗胃食管反流病(GERD)是否能改善患有哮喘和GERD的儿童的哮喘症状?一项系统评价。
J Investig Allergol Clin Immunol. 2009;19(1):1-5.
5
Proton pump inhibitors for functional dyspepsia.用于功能性消化不良的质子泵抑制剂。
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011194. doi: 10.1002/14651858.CD011194.pub3.
6
Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.腹腔镜 Nissen 胃底折叠术与经口无切口胃底折叠术或质子泵抑制剂治疗胃食管反流病的疗效比较:系统评价和网络荟萃分析。
Gastroenterology. 2018 Apr;154(5):1298-1308.e7. doi: 10.1053/j.gastro.2017.12.021. Epub 2018 Jan 3.
7
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.
8
Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease.系统评价:质子泵抑制剂对胃食管反流病患者症状缓解与健康相关生活质量的相关性。
Aliment Pharmacol Ther. 2011 Sep;34(6):618-27. doi: 10.1111/j.1365-2036.2011.04774.x. Epub 2011 Jul 20.
9
Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review.质子泵抑制剂治疗儿童胃食管反流病的疗效:系统评价。
Pediatrics. 2011 May;127(5):925-35. doi: 10.1542/peds.2010-2719. Epub 2011 Apr 4.
10
Providing physicians with feedback on medication adherence for people with chronic diseases taking long-term medication.为正在服用长期药物的慢性病患者的用药依从性向医生提供反馈。
Cochrane Database Syst Rev. 2018 Jan 10;1(1):CD012042. doi: 10.1002/14651858.CD012042.pub2.

引用本文的文献

1
Knowledge, Attitudes, and Practices of Community Pharmacists Regarding Proton Pump Inhibitor (PPI) Use: A Cross-Sectional Study.社区药剂师对质子泵抑制剂(PPI)使用的知识、态度和实践:一项横断面研究。
Healthcare (Basel). 2025 Jul 2;13(13):1588. doi: 10.3390/healthcare13131588.
2
Trends in Proton-Pump Inhibitor Use Among Danish Adults: A Nationwide Drug Utilization Study 2015-2023.丹麦成年人使用质子泵抑制剂的趋势:一项2015 - 2023年的全国性药物使用研究
Basic Clin Pharmacol Toxicol. 2025 Jun;137(1):e70057. doi: 10.1111/bcpt.70057.
3
Trends in Proton Pump Inhibitor Use in Sweden by Sex and Age: A Drug Utilisation Study.
瑞典按性别和年龄划分的质子泵抑制剂使用趋势:一项药物利用研究。
Drug Saf. 2025 Apr;48(4):389-400. doi: 10.1007/s40264-024-01502-9. Epub 2024 Dec 8.
4
Network meta-analysis of multiple doses of vonoprazan for the treatment of erosive esophagitis.网络荟萃分析多种剂量 vonoprazan 治疗糜烂性食管炎。
J Comp Eff Res. 2023 Aug;12(8):e220165. doi: 10.57264/cer-2022-0165. Epub 2023 Jul 20.
5
Improving Patient Adherence to Lifestyle Changes for the Management of Gastroesophageal Reflux.提高患者对生活方式改变的依从性以管理胃食管反流
Patient Prefer Adherence. 2022 Apr 5;16:897-909. doi: 10.2147/PPA.S356466. eCollection 2022.
6
A Randomized Placebo-Controlled -of-1 Trial: The Effect of Proton Pump Inhibitor in the Management of Gastroesophageal Reflux Disease.质子泵抑制剂治疗胃食管反流病的随机安慰剂对照 1 期试验。
Can J Gastroenterol Hepatol. 2019 Dec 12;2019:3926051. doi: 10.1155/2019/3926051. eCollection 2019.
7
Sustained proton pump inhibitor deprescribing among dyspeptic patients in general practice: a return to self-management through a programme of education and alginate rescue therapy. A prospective interventional study.全科医疗中消化不良患者持续停用质子泵抑制剂:通过教育和海藻酸盐补救治疗方案回归自我管理。一项前瞻性干预研究。
BJGP Open. 2019 Oct 29;3(3). doi: 10.3399/bjgpopen19X101651. Print 2019 Oct.
8
Perceptions of patient-centered care among Veterans with gastroesophageal reflux disease on proton pump inhibitor therapy.接受质子泵抑制剂治疗的胃食管反流病退伍军人对以患者为中心的护理的认知
Patient Exp J. 2018;5(3):149-159. doi: 10.35680/2372-0247.1232.
9
Attitude and knowledge of Saudi community pharmacists towards use of proton pump inhibitors.沙特社区药剂师对质子泵抑制剂使用的态度和知识
Saudi Pharm J. 2019 Feb;27(2):225-228. doi: 10.1016/j.jsps.2018.11.002. Epub 2018 Nov 7.
10
Vonoprazan versus proton pump inhibitors for the management of gastroesophageal reflux disease: A protocol for a systematic review with meta-analysis.沃克酰胺与质子泵抑制剂治疗胃食管反流病的比较:一项系统评价与荟萃分析方案
Medicine (Baltimore). 2018 Sep;97(39):e12574. doi: 10.1097/MD.0000000000012574.